BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17074584)

  • 1. Association between telomere length and BCL2 gene rearrangements in low- and high-grade non-Hodgkin lymphomas.
    Haydeé Cottliar AS; Noriega MF; Narbaitz M; Rodríguez A; Slavutsky IR
    Cancer Genet Cytogenet; 2006 Nov; 171(1):1-8. PubMed ID: 17074584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular analysis of telomere length in follicular lymphomas. Its participation in tumor progression].
    Cottliar AS; Noriega MF; Narbaitz M; Slavutsky IR
    Medicina (B Aires); 2005; 65(2):143-6. PubMed ID: 16075809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 gene rearrangement in Jordanian follicular and diffuse large B-cell lymphomas.
    Almasri NM; Al-Alami J; Faza M
    Saudi Med J; 2005 Feb; 26(2):251-5. PubMed ID: 15770300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of telomere length in mantle cell lymphoma.
    Cottliar AS; Panero J; Pedrazzini E; Noriega MF; Narbaitz M; Rodríguez A; Slavutsky I
    Eur J Haematol; 2009 Nov; 83(5):433-8. PubMed ID: 19594618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and Southern transfer analysis.
    Chibbar R; Leung K; McCormick S; Ritzkalla K; Strickler J; Staggs R; Poppema S; Brunning RD; McGlennen RC
    Mod Pathol; 1998 Nov; 11(11):1089-97. PubMed ID: 9831207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR.
    Batstone PJ; Goodlad JR
    J Clin Pathol; 2005 Jan; 58(1):81-2. PubMed ID: 15623489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of BCL-2 gene rearrangements in Argentinean non-Hodgkin lymphoma patients: increased frequency of breakpoints outside of MBR and MCR.
    Noriega MF; De Brasi C; Narbaitz M; Slavutsky I
    Blood Cells Mol Dis; 2004; 32(1):232-9. PubMed ID: 14757440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL2 complex rearrangement in follicular lymphoma: translocation mbr/JH and deletion in the vcr region of the same BCL2 allele.
    Séité P; Hillion J; d'Agay MF; Berger R; Larsen CJ
    Oncogene; 1993 Nov; 8(11):3073-80. PubMed ID: 8414508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
    Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
    Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental factors may regulate BCL2 associated lymphomagenesis: a very low incidence of BCL2-MBR translocation in Poland.
    Lubiński J; Podolski J; Hadaczek P; Mioduszewska O; Rylski M; Huebner K
    Pol J Pathol; 1995; 46(4):219-24. PubMed ID: 8713288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas.
    Walsh SH; Grabowski P; Berglund M; Thunberg U; Thorsélius M; Tobin G; Aleskog A; Karlsson K; Sundström C; Laurell A; Enblad G; Rosenquist R; Roos G
    Eur J Haematol; 2007 Apr; 78(4):283-9. PubMed ID: 17286609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetic study on 155 cases of non-Hodgkin' s lymphoma].
    Wang XQ;
    Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):656-60. PubMed ID: 17343195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
    Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P
    Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BCL-2/IgH and IgH gene rearrangements in bone marrow mononuclear cells of patients with non-Hodgkin's lymphoma].
    Zhang XH; Liang Y; Wang GJ; Ruan EB; Fu R; Qu W; Liu H; Guan J; Song J; Wang HQ; Wu YH; Xing LM; Wang XM; Wang J; Li LJ; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):379-84. PubMed ID: 21518492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
    Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M
    Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B.
    Bosga-Bouwer AG; Haralambieva E; Booman M; Boonstra R; van den Berg A; Schuuring E; van den Berg E; Kluin P; Poppema S
    Genes Chromosomes Cancer; 2005 Nov; 44(3):301-4. PubMed ID: 16075463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
    Niitsu N; Okamoto M; Nakamura N; Nakamine H; Aoki S; Hirano M; Miura I
    Leuk Res; 2007 Sep; 31(9):1191-7. PubMed ID: 17197022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.